Shots:

• 3M is working with MIT’s researcher to develop a rapid COVID-19 diagnostic using a simple- paper-based test that detects viral antigens and produces accurate results within minutes and is feasible to mass manufacture
• The collaboration leverages 3M’s expertise in biomaterials and bioprocessing along with the global medical device manufacturing capabilities. 3M and MIT believe a diagnostic test can be deployed once validated and expect to produce millions of units/ day
• NIH has supported the project under competitive Rapid Acceleration of Diagnostics Tech (RADx Tech) program launched in early May to combat COVID-19. The project received $500-000 for validation funding from RADx Tech and is eligible for further investment in later stages of the development

Click here to­ read full press release/ article | Ref: Businesswire | Image: Pinterest